Chronic kidney disease (CKD) is one of the most important risk factors for cardiovascular
disease (CVD). Despite the kidney having no direct implications for lipoproteins metabolism …

Rates of cardiovascular mortality are disproportionately high in patients with end stage
kidney disease receiving dialysis. However, it is now generally accepted that patient survival …

Background Acute myocardial injury (AMI), which is induced by renal ischemia-reperfusion
(IR), is a significant cause of acute kidney injury (AKI)-related associated death. Obesity …

BACKGROUND: A large body of research has investigated the effects of pro-atherogenic
lipid profile on cardiovascular diseases (CVD) in peritoneal dialysis (PD) patients. However …

Abstract Background/Aims: This study aimed to evaluate total and sudden death (SD) in a
cohort of dialysis patients, comparing hemodialysis (HD) vs. peritoneal dialysis (PD) …

The high prevalence of chronic kidney disease leads to an increased need for renal
replacement therapies. While there are simply not enough donor organs available for …

Objectives Homocysteine is a modifiable, independent risk factor for cardiovascular disease.
The association between hyperhomocysteinemia and metabolic syndrome with the …

Urea at post-dialysis levels induces increased ROS in a number of cell types. The aim of this
study was to determine whether urea-induced production of ROS remains elevated after …

Background Tissue remodeling is usually dependent on the deposition of extracellular
matrix that may result in tissue stiffness and impaired myocardium contraction. Objectives …

Purpose Major cardiovascular events (MACE) are the leading cause of mortality in patients
with chronic kidney disease. Although hemodialysis (HD) and peritoneal dialysis (PD) are …